Evidence map›Paper›PMID 42357818›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Nitric Oxide Conjugation Transforms NIR-II AIEgens Into Potent Hypoxia-Tolerant Type I Photosensitizers.

Junjun Ni, Yan Feng, Jianquan Zhang, Muhammad Muazzam Naseer, Liang Guo, Kunpeng Feng, Ryan T K Kwok, Jacky W Y Lam, Lianrui Hu, Xiaoran Yin and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Junjun NiBioinspired Engineering and Biomechanics Center (BEBC), School of Life Science and Technology, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Xi'an Jiaotong University, Xi'an, P. R. China.
Yan FengDepartment of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P. R. China.ORCID https://orcid.org/0000-0002-6332-565X
Jianquan ZhangGuangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen, Guangdong, P. R. China.ORCID https://orcid.org/0000-0003-4528-9824
Muhammad Muazzam NaseerBioinspired Engineering and Biomechanics Center (BEBC), School of Life Science and Technology, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Xi'an Jiaotong University, Xi'an, P. R. China.
Liang GuoBioinspired Engineering and Biomechanics Center (BEBC), School of Life Science and Technology, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Xi'an Jiaotong University, Xi'an, P. R. China.ORCID https://orcid.org/0000-0001-6520-6331
Kunpeng FengBioinspired Engineering and Biomechanics Center (BEBC), School of Life Science and Technology, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Xi'an Jiaotong University, Xi'an, P. R. China.
Ryan T K KwokDepartment of Chemistry, Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, Division of Life Science, State Key Laboratory of Nervous System Disorders, and Department of Chemical and Biological Engineering, The Hong Kong University of Science & Technology, Kowloon, Hong Kong, P. R. China.ORCID https://orcid.org/0000-0002-6866-3877
Jacky W Y LamDepartment of Chemistry, Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, Division of Life Science, State Key Laboratory of Nervous System Disorders, and Department of Chemical and Biological Engineering, The Hong Kong University of Science & Technology, Kowloon, Hong Kong, P. R. China.
Lianrui HuShanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Shanghai Frontiers Science Center of Molecule Intelligent Syntheses, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, P. R. China.
Xiaoran YinDepartment of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P. R. China.
Guorui JinBioinspired Engineering and Biomechanics Center (BEBC), School of Life Science and Technology, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Xi'an Jiaotong University, Xi'an, P. R. China.
Ben Zhong TangGuangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen, Guangdong, P. R. China.ORCID https://orcid.org/0000-0002-0293-964X

Funding

Guangdong Basic Research Center of Excellence for Aggregate ScienceInnovation and Technology Commission of Hong Kong ITC-CNERC14SC01Key Medical Research Project of Xi'an Science and Technology Plan 25YXYJZD00008Key Projects of the Xiangyang Innovation and Development Joint FundKey R&D Program of Shaanxi Province 2024SF2-GJHX-31National Key R&D Program of China 2021YFE0202400National Natural Science Foundation of China 22575206National Natural Science Foundation of China 31971293Natural Science Foundation of Hubei Province 2025AFD053Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ20240813113538049Science, Technology and Innovation Commission of Shenzhen Municipality KQTD20210811090142053
6 · The paper itself

Abstract

Near-infrared (NIR)-activated type I photosensitizers (PSs) with aggregation-induced emission (AIE) properties are highly attractive for photodynamic therapy (PDT) of deep-seated and inoperable tumors. However, most NIR-activated AIEgens, especially donor-acceptor-donor (D-A-D) benzobisthiadiazole derivatives, are mainly used for bioimaging and photothermal therapy due to their intrinsically small S

Indexed as

Infrared RaysNitric OxidePhotosensitizing AgentsAnimalsCell Line, TumorHumansMicePhotochemotherapyReactive Oxygen SpeciesThiadiazolesNitric OxidePhotosensitizing AgentsReactive Oxygen SpeciesThiadiazolesaggregation‐induced emissionhypoxia‐tolerant photodynamic therapyNIR‐II fluorescencenitric oxidetype I photosensitizer

Identifiers

PMID42357818
PMCPMC13431957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.